{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:54:31Z","timestamp":1756461271691,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>RPP25, a 25 kDa protein subunit of ribonuclease P (RNase P), is a protein-coding gene. Disorders associated with RPP25 include chromosome 15Q24 deletion syndrome and diffuse scleroderma, while systemic sclerosis can be complicated by malignancy. However, the functional role of RPP25 expression in glioblastoma multiforme (GBM) is unclear. In this study, comprehensive bioinformatics analysis was used to evaluate the impact of RPP25 on GBM occurrence and prognosis. Differential analysis of multiple databases showed that RPP25 was commonly highly expressed in multiple cancers but lowly expressed in GBM. Survival prognostic results showed that RPP25 was prognostically relevant in six tumors (CESC, GBM, LAML, LUAD, SKCM, and UVM), but high RPP25 expression was significantly associated with poor patient prognosis except for CESC. Analysis of RPP25 expression in GBM alone revealed that RPP25 was significantly downregulated in GBM compared with normal tissue. Receiver operating characteristic (ROC) combined with Kaplan-Meier (KM) analysis and Cox regression analysis showed that high RPP25 expression was a prognostic risk factor for GBM and had a predictive value for the 1-year, 2-year, and 3-year survival of GBM patients. In addition, the expression of RPP25 was correlated with the level of immune cell infiltration. The gene set enrichment analysis (GSEA) results showed that RPP25 was mainly associated with signalling pathways related to tumor progression and tumor metabolism.<\/jats:p>","DOI":"10.3389\/fonc.2021.714904","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T10:54:42Z","timestamp":1641984882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Dongdong","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingnan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuansheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in Systemic Sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131450","article-title":"Autoantibodies to the Rpp25 Component of the Th\/To Complex Are the Most Common Antibodies in Patients With Systemic Sclerosis Without Antibodies Detectable by Widely Available Commercial Tests","volume":"41","author":"Mahler","year":"2014","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.10673","article-title":"Identity of the RNase MRP\u2013and RNase P\u2013associated Th\/To Autoantigen","volume":"46","author":"Van Eenennaam","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01991.x","article-title":"Autoantibodies Against Small Nucleolar Ribonucleoprotein Complexes and Their Clinical Associations","volume":"130","author":"Van Eenennaam","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.9.842","article-title":"Differences in Autoantibody Response to Th\/To Between Systemic Sclerosis and Other Autoimmune Diseases","volume":"61","author":"Kuwana","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0519-x","article-title":"Glioma Subclassifications and Their Clinical Significance","volume":"14","author":"Chen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox183","article-title":"Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications","volume":"20","author":"Malta","year":"2018","journal-title":"Neuro-Oncology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201302627","article-title":"Emerging Treatment Strategies for Glioblastoma Multiforme","volume":"6","author":"Carlsson","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"eabc2511","DOI":"10.1126\/sciadv.abc2511","article-title":"Regulation of Tumor Immune Suppression and Cancer Cell Survival by CXCL1\/2 Elevation in Glioblastoma Multiforme","volume":"7","author":"Hu","year":"2021","journal-title":"Sci Adv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1314-0","article-title":"The Prognostic Value of Foxp3+ Tumor-Infiltrating Lymphocytes in Patients With Glioblastoma","volume":"116","author":"Yue","year":"2014","journal-title":"J\u00a0Neuro Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation Stabilizes ATP-Citrate Lyase to Promote Lipid Biosynthesis and Tumor Growth","volume":"51","author":"Lin","year":"2013","journal-title":"Mol Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci Trans Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0139-3","article-title":"Targeting Cancer Cell Metabolism in Glioblastoma","volume":"19","author":"Crunkhorn","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07232-8","article-title":"Pan-Cancer Analysis of Transcriptional Metabolic Dysregulation Using The Cancer Genome Atlas","volume":"9","author":"Rosario","year":"2018","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01631","article-title":"Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer Cell Metabolic Reprogramming: A Keystone for the Response to Immunotherapy[J]","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Discov"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cells9102308","article-title":"Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets[J]","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"The Warburg Effect and Metabolic Efficiency: Re-Crunching the Numbers","volume":"324","author":"Koppenol","year":"2009","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer Cell Metabolism: Warburg and Beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.8.6.519","article-title":"The Metabolism of Tumors in the Body","volume":"8","author":"Warburg","year":"1927","journal-title":"J\u00a0Gen Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2763","article-title":"Signal Integration by Mtorc1 Coordinates Nutrient Input With Biosynthetic Output","volume":"15","author":"Dibble","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00482","article-title":"Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues","volume":"9","author":"Civita","year":"2019","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR Signaling in Growth Control and Disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"mTOR, Metabolism, and the Regulation of T-Cell Differentiation and Function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12380","article-title":"Chronic mTOR Inhibition in Mice With Rapamycin Alters T, B, Myeloid, and Innate Lymphoid Cells and Gut Flora and Prolongs Life of Immune-Deficient Mice","volume":"14","author":"Hurez","year":"2015","journal-title":"Aging Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation Between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0363","article-title":"Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism","volume":"73","author":"Mirzaa","year":"2016","journal-title":"JAMA Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nm.3824","article-title":"Brain Somatic Mutations in MTOR Cause Focal Cortical Dysplasia Type II Leading to Intractable Epilepsy","volume":"21","author":"Lim","year":"2015","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.20.8809-8823.2005","article-title":"mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells","volume":"25","author":"Panner","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3546","article-title":"mTOR Complexes in Neurodevelopmental and Neuropsychiatric Disorders","volume":"16","author":"Costa-Mattioli","year":"2013","journal-title":"Nat Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12057","article-title":"mTOR Regulates Tau Phosphorylation and Degradation: Implications for Alzheimer\u2019s Disease and Other Tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.048","article-title":"Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase \u03b7 in the Alternative Lengthening of Telomeres","volume":"17","author":"Garcia-Exposito","year":"2016","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1017\/S1355838202027954","article-title":"Purification and Characterization of Rpp25, an RNA-Binding Protein Subunit of Human Ribonuclease P","volume":"8","author":"Guerrier-Takada","year":"2002","journal-title":"Rna"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.3.945-953.2004","article-title":"RNase MRP Cleaves the CLB2 mRNA to Promote Cell Cycle Progression: Novel Method of mRNA Degradation","volume":"24","author":"Gill","year":"2004","journal-title":"Mol Cell Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.714904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T10:54:49Z","timestamp":1641984889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.714904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":38,"alternative-id":["10.3389\/fonc.2021.714904"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.714904","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"article-number":"714904"}}